Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. B 5, Vitamin
2. B5, Vitamin
3. Dexol
4. Pantothenate, Calcium
5. Pantothenate, Zinc
6. Pantothenic Acid
7. Vitamin B 5
8. Vitamin B5
9. Zinc Pantothenate
1. 137-08-6
2. D-calcium Pantothenate
3. Calpanate
4. Pantholin
5. Calpan
6. Vitamin B5, Calcium Salt
7. Calcium D-pantothenate
8. Pantothenate Calcium
9. D-ca Pantothenate
10. Calcium Pantotenate
11. Pantothenic Acid Calcium Salt
12. Pancal
13. Calcium D-pantothenate (1:2)
14. D-pantothenic Acid Calcium Salt
15. Cris Pan
16. Calcium Pantothenate, D-
17. Calcium Panthothenate
18. Ca-hopa
19. Pantothenic Acid (as Calcium)
20. D-pantothenic Acid Hemicalcium
21. Pantothenic Acid, Calcium Salt (2:1), D-
22. Dextro Calcium Pantothenate
23. 568et80c3d
24. Calcium Pantothenate (2:1)
25. Nsc-36292
26. Pantothenic Acid, Calcium Salt
27. D-pantothenic Acid Hemicalcium Salt
28. Calcium D-panthotenate
29. Pantothenic Acid Calcium
30. Calcium (r)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate
31. D-calcium Pantothenate Calcium Chloride Double Salt
32. Calcii Pantothenas
33. Pantotenato Calcico
34. N-(2,4-dihydroxy-3,3-dimethylbutyryl)-beta-alanine Calcium
35. Calcium;3-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate
36. Pantothenate De Calcium
37. Bis(pantothenato)calcium
38. Ncgc00183031-01
39. Calcium Pantothenate (van)
40. Calcium, Bis(pantothenato)-
41. Calcium Pantothenate , D-form
42. Unii-568et80c3d
43. Ccris 1338
44. Mfcd00002766
45. Calcii Pantothenas [inn-latin]
46. Pantotenato Calcico [inn-spanish]
47. Einecs 205-278-9
48. Calcium Pantothenate [usp:inn:jan]
49. Calpan (tn)
50. Nsc 36292
51. Pantothenate De Calcium [inn-french]
52. Vitamin B5 Calcium Salt
53. Pantothenic Acid, Calcium Salt, D-, Compd. With Calcium Chloride
54. D-pantothenic Acid Calcium
55. Pantothenic Acid, Calcium Salt (2:1), (+)-
56. D-pantothenicacidhemicalcium
57. Calcium D-(+)-pantothenate
58. Dsstox_cid_20438
59. Dsstox_rid_79493
60. Dsstox_gsid_40438
61. Schembl34427
62. Chembl1901349
63. Dtxsid8040438
64. Chebi:31345
65. Calcium Pantothenate [inn]
66. Calcium Pantothenate [jan]
67. Calcium Pantothenate [inci]
68. Calcium Pantothenate [vandf]
69. Calcium Pantothenate, (+)-
70. Tox21_113437
71. Calcium Pantothenate [usp-rs]
72. Calcium Pantothenate [who-dd]
73. Akos024258157
74. Calcium Pantothenate (jp17/usp/inn)
75. Beta-alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Calcium Salt (2:1), (r)-
76. Calcium D(+)-n-(alpha,gamma-dihydroxy-beta,beta-dimethylbutyryl)-beta-alaninate
77. Calcium N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine (1:2), (r)-
78. As-13049
79. Calcium Pantothenate [ep Impurity]
80. Cas-137-08-6
81. (+)-pantothenic Acid Calcium Salt
82. Calcium Pantothenate [ep Monograph]
83. Pantothenic Acid Calcium Salt [mi]
84. Calcium Pantothenate [usp Monograph]
85. P0012
86. Pantothenic Acid (as Calcium) [vandf]
87. D01082
88. D70806
89. A807185
90. Pantothenic Acid (as Calcium Pantothenate)
91. Pantothenic Acid Calcium 10 Microg/ml In Acetonitrile
92. Q27261387
93. Calcium N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine
94. Beta-alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Calcium Salt
95. Calcium 3-[[(2r)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propanoate
96. .beta.-alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Calcium Salt (2:1), (r)-
97. Beta-alanine, N-((2r)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Calcium Salt (2:1)
98. Beta-alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Calcium Salt (2:1), (theta)-
Molecular Weight | 476.5 g/mol |
---|---|
Molecular Formula | C18H32CaN2O10 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 476.1682861 g/mol |
Monoisotopic Mass | 476.1682861 g/mol |
Topological Polar Surface Area | 219 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 233 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
A - Alimentary tract and metabolism
A11 - Vitamins
A11H - Other plain vitamin preparations
A11HA - Other plain vitamin preparations
A11HA31 - Calcium pantothenate
D - Dermatologicals
D03 - Preparations for treatment of wounds and ulcers
D03A - Cicatrizants
D03AX - Other cicatrizants
D03AX04 - Calcium pantothenate
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Calcium Pantothenate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Pantothenate manufacturer or Calcium Pantothenate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Pantothenate manufacturer or Calcium Pantothenate supplier.
PharmaCompass also assists you with knowing the Calcium Pantothenate API Price utilized in the formulation of products. Calcium Pantothenate API Price is not always fixed or binding as the Calcium Pantothenate Price is obtained through a variety of data sources. The Calcium Pantothenate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A P2250_SIAL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of P2250_SIAL, including repackagers and relabelers. The FDA regulates P2250_SIAL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. P2250_SIAL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of P2250_SIAL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A P2250_SIAL supplier is an individual or a company that provides P2250_SIAL active pharmaceutical ingredient (API) or P2250_SIAL finished formulations upon request. The P2250_SIAL suppliers may include P2250_SIAL API manufacturers, exporters, distributors and traders.
click here to find a list of P2250_SIAL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The P2250_SIAL Drug Master File in Japan (P2250_SIAL JDMF) empowers P2250_SIAL API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the P2250_SIAL JDMF during the approval evaluation for pharmaceutical products. At the time of P2250_SIAL JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of P2250_SIAL suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a P2250_SIAL Drug Master File in Korea (P2250_SIAL KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of P2250_SIAL. The MFDS reviews the P2250_SIAL KDMF as part of the drug registration process and uses the information provided in the P2250_SIAL KDMF to evaluate the safety and efficacy of the drug.
After submitting a P2250_SIAL KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their P2250_SIAL API can apply through the Korea Drug Master File (KDMF).
click here to find a list of P2250_SIAL suppliers with KDMF on PharmaCompass.
P2250_SIAL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of P2250_SIAL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right P2250_SIAL GMP manufacturer or P2250_SIAL GMP API supplier for your needs.
A P2250_SIAL CoA (Certificate of Analysis) is a formal document that attests to P2250_SIAL's compliance with P2250_SIAL specifications and serves as a tool for batch-level quality control.
P2250_SIAL CoA mostly includes findings from lab analyses of a specific batch. For each P2250_SIAL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
P2250_SIAL may be tested according to a variety of international standards, such as European Pharmacopoeia (P2250_SIAL EP), P2250_SIAL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (P2250_SIAL USP).